Venkata Yellepeddi, Ph.D.
Assistant Professor of Pharmaceutical Sciences
Roseman University of Health Sciences
My research involves the development of a preservative-free nasal spray of prochlorperazine for the treatment of migraine. Migraine affects more than 37 million people in the U.S. and almost 5 million experience, at least, one migraine attack per month. The novelty of my research involves in the development of a nasal spray of prochlorperazine that can be easily used by patients suffering from a migraine attack.
Promotion by AAPS of my research enhanced the confidence of my University towards the success of my research and led to the filing of a provisional patent for a nasal spray of prochlorperazine by our university. As an upcoming faculty in the field of pharmaceutical sciences, promotion of my research by AAPS resulted in expanding my scientific network and allowed me to obtain new collaborations in academia, industry, and FDA. Because of AAPS promotion of my research in the media, I received consents from many migraine patients to participate in clinical trials of my formulation. Furthermore, I was also contacted by a company which is currently involved in the development of devices for nasal spray and was willing to provide me with their devices free of cost for testing. Currently, I am working on submitting an R21 grant to NIH based on my research on prochlorperazine nasal spray.